Preap­proval and oth­er man­u­fac­tur­ing in­spec­tions: FDA re­vis­es two com­pli­ance guides

The FDA’s re­vi­sions of two com­pli­ance pro­grams — large­ly re­lat­ed to the in­tro new ICH work — deal with preap­proval and oth­er drug man­u­fac­tur­ing in­spec­tions and went …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER